Skip to main content
Top
Published in: Neurological Sciences 1/2019

Open Access 01-01-2019 | Original Article

The Italian multiple sclerosis register

Authors: Maria Trojano, Roberto Bergamaschi, Maria Pia Amato, Giancarlo Comi, Angelo Ghezzi, Vito Lepore, Maria Giovanna Marrosu, Paola Mosconi, Francesco Patti, Michela Ponzio, Paola Zaratin, Mario Alberto Battaglia, on behalf of the Italian Multiple Sclerosis Register Centers Group

Published in: Neurological Sciences | Issue 1/2019

Login to get access

Abstract

The past decade has seen extraordinary increase in worldwide availability of and access to several large multiple sclerosis (MS) databases and registries. MS registries represent powerful tools to provide meaningful information on the burden, natural history, and long-term safety and effectiveness of treatments. Moreover, patients, physicians, industry, and policy makers have an active interest in real-world observational studies based on register data, as they have the potential to answer the questions that are most relevant to daily treatment decision-making. In 2014, the Italian MS Foundation, in collaboration with the Italian MS clinical centers, promoted and funded the creation of the Italian MS Register, a project in continuity with the existing Italian MS Database Network set up from 2001. Main objective of the Italian MS Register is to create an organized multicenter structure to collect data of all MS patients for better defining the disease epidemiology, improving quality of care, and promoting research projects in high-priority areas. The aim of this article is to present the current framework and network of the Italian MS register, including the methodology used to improve the quality of data collection and to facilitate the exchange of data and the collaboration among national and international groups.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gliklich RE, Leavy MB (2014) Registries for evaluating patient outcomes: a User's Guide, 3rd edn. Agency for Healthcare Research and Quality (US), Rockville Gliklich RE, Leavy MB (2014) Registries for evaluating patient outcomes: a User's Guide, 3rd edn. Agency for Healthcare Research and Quality (US), Rockville
2.
go back to reference Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H (2017) Treatment decisions in multiple sclerosis—insights from real-world observational studies. Nat Rev Neurol 13:105–118CrossRef Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, Spelman T, Sormani MP, Butzkueven H (2017) Treatment decisions in multiple sclerosis—insights from real-world observational studies. Nat Rev Neurol 13:105–118CrossRef
3.
go back to reference De Groot S, van der Linden N, Franken MG et al (2017) Balancing the optimal and the feasible: a practical guide for setting up patient registries for the collection of real-world data for health care decision making based on Dutch experiences. Value Health 20:627–636CrossRef De Groot S, van der Linden N, Franken MG et al (2017) Balancing the optimal and the feasible: a practical guide for setting up patient registries for the collection of real-world data for health care decision making based on Dutch experiences. Value Health 20:627–636CrossRef
4.
go back to reference Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli Ö, for the EUReMS Consortium* (2014) Consortium EU. Multiple sclerosis registries in Europe—results of a systematic survey. Mult Scler 20(11):1523–1532CrossRef Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli Ö, for the EUReMS Consortium* (2014) Consortium EU. Multiple sclerosis registries in Europe—results of a systematic survey. Mult Scler 20(11):1523–1532CrossRef
5.
go back to reference Trojano M, Granieri E, Rosati G et al (2003) In: abstracts from the 19th congress of the European Committee for Treatment and Research in Multiple Sclerosis, Milan, Italy Trojano M, Granieri E, Rosati G et al (2003) In: abstracts from the 19th congress of the European Committee for Treatment and Research in Multiple Sclerosis, Milan, Italy
6.
go back to reference Trojano M, Liguori M, Paolicelli D, Zimatore GB, de Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P, Southern Italy MS Group (2003) An independent post-marketing study in southern Italy. Mult Scler 9:451–445CrossRef Trojano M, Liguori M, Paolicelli D, Zimatore GB, de Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P, Southern Italy MS Group (2003) An independent post-marketing study in southern Italy. Mult Scler 9:451–445CrossRef
7.
go back to reference Mechati S, Peyro-St-Paul H (2001) iMed: a new electronic database for monitoring patients with multiple sclerosis. Mult Scler 7:S31–S31 Mechati S, Peyro-St-Paul H (2001) iMed: a new electronic database for monitoring patients with multiple sclerosis. Mult Scler 7:S31–S31
8.
go back to reference Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRef Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRef
9.
go back to reference Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173CrossRef Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173CrossRef
10.
go back to reference Koch-Henriksen N, Magyari M, Laursen B (2015) Registers of multiple sclerosis in Denmark. Acta Neurol Scand 132:4–10CrossRef Koch-Henriksen N, Magyari M, Laursen B (2015) Registers of multiple sclerosis in Denmark. Acta Neurol Scand 132:4–10CrossRef
11.
go back to reference Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH (2015) The Norwegian multiple sclerosis registry and biobank. Acta Neurol Scand 132:24–28CrossRef Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH (2015) The Norwegian multiple sclerosis registry and biobank. Acta Neurol Scand 132:24–28CrossRef
12.
go back to reference Hillert J, Stawiarz L (2015) The Swedish MS registry—clinical support tool and scientific resource. Acta Neurol Scand 132:11–19CrossRef Hillert J, Stawiarz L (2015) The Swedish MS registry—clinical support tool and scientific resource. Acta Neurol Scand 132:11–19CrossRef
13.
go back to reference Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T (2007) Validation of the NARCOMS registry: diagnosis. Mult Scler 13:770–775CrossRef Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T (2007) Validation of the NARCOMS registry: diagnosis. Mult Scler 13:770–775CrossRef
14.
go back to reference Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55(8):671–676CrossRef Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55(8):671–676CrossRef
15.
go back to reference Cotton F, Kremer S, Hannoun S, Vukusic S, Dousset V, Imaging Working Group of the Observatoire Français de la Sclérose en Plaques (2015) OFSEP, a nationwide cohort of people with multiple sclerosis: consensus minimal MRI protocol. J Neuroradiol 42(3):133–140CrossRef Cotton F, Kremer S, Hannoun S, Vukusic S, Dousset V, Imaging Working Group of the Observatoire Français de la Sclérose en Plaques (2015) OFSEP, a nationwide cohort of people with multiple sclerosis: consensus minimal MRI protocol. J Neuroradiol 42(3):133–140CrossRef
16.
go back to reference Stuke K, Flachenecker P, Zettl U et al (2008) MS register in Germany: update 2007. J Neurol 255(2):II81 Stuke K, Flachenecker P, Zettl U et al (2008) MS register in Germany: update 2007. J Neurol 255(2):II81
17.
go back to reference Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F, Malkowski JP (2006) MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler 12:769–774CrossRef Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F, Malkowski JP (2006) MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler 12:769–774CrossRef
18.
go back to reference Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci 38(3):473–479CrossRef Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci 38(3):473–479CrossRef
19.
go back to reference Trojano M, Russo P, Fuiani A, Paolicelli D, di Monte E, Granieri E, Rosati G, Savettieri G, Comi G, Livrea P, MSDN Study Group (2006) The Italian multiple sclerosis database network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis. Mult Scler 12(5):578–585CrossRef Trojano M, Russo P, Fuiani A, Paolicelli D, di Monte E, Granieri E, Rosati G, Savettieri G, Comi G, Livrea P, MSDN Study Group (2006) The Italian multiple sclerosis database network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis. Mult Scler 12(5):578–585CrossRef
20.
go back to reference Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, di Monte E, Portaccio E, Lepore V, Livrea P, Amato MP (2007) New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 61(4):300–306CrossRef Trojano M, Pellegrini F, Fuiani A, Paolicelli D, Zipoli V, Zimatore GB, di Monte E, Portaccio E, Lepore V, Livrea P, Amato MP (2007) New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol 61(4):300–306CrossRef
21.
go back to reference Bergamaschi R, Quaglini S, Trojano M et al (2007) Early prediction of the long-term evolution of multiple sclerosis: the Bayesian risk estimate for multiple sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry 78(7):757–759CrossRef Bergamaschi R, Quaglini S, Trojano M et al (2007) Early prediction of the long-term evolution of multiple sclerosis: the Bayesian risk estimate for multiple sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry 78(7):757–759CrossRef
22.
go back to reference Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Zipoli V, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Lepore V, Livrea P, Comi G, Amato MP, Italian Multiple Sclerosis Database Network (MSDN) Group (2009) Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol 66(4):513–520CrossRef Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Zipoli V, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Lepore V, Livrea P, Comi G, Amato MP, Italian Multiple Sclerosis Database Network (MSDN) Group (2009) Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol 66(4):513–520CrossRef
23.
go back to reference Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Portaccio E, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Iaffaldano P, Direnzo V, D'Onghia M, Lepore V, Livrea P, Comi G, Amato MP, Italian Multiple Sclerosis Database Network Group (2009) Italian multiple sclerosis database network group. Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment. J Neurol Sci 286(1–2):109–113CrossRef Trojano M, Pellegrini F, Paolicelli D, Fuiani A, Zimatore GB, Tortorella C, Simone IL, Patti F, Ghezzi A, Portaccio E, Rossi P, Pozzilli C, Salemi G, Lugaresi A, Bergamaschi R, Millefiorini E, Clerico M, Lus G, Vianello M, Avolio C, Cavalla P, Iaffaldano P, Direnzo V, D'Onghia M, Lepore V, Livrea P, Comi G, Amato MP, Italian Multiple Sclerosis Database Network Group (2009) Italian multiple sclerosis database network group. Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment. J Neurol Sci 286(1–2):109–113CrossRef
24.
go back to reference Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D’Onghia M, Garberi F, Bargiggia V, Trojano M (2016) Immunomodulatory therapies delay disease progression in multiple sclerosis. Mult Scler 22(13):1732–1740CrossRef Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D’Onghia M, Garberi F, Bargiggia V, Trojano M (2016) Immunomodulatory therapies delay disease progression in multiple sclerosis. Mult Scler 22(13):1732–1740CrossRef
25.
go back to reference Bebo BF, Fox RJ, Lee K et al (2017) Landscape of MS patient cohorts and registries: recommendations for maximizing impact. Mult Scler 24(5):579–586CrossRef Bebo BF, Fox RJ, Lee K et al (2017) Landscape of MS patient cohorts and registries: recommendations for maximizing impact. Mult Scler 24(5):579–586CrossRef
Metadata
Title
The Italian multiple sclerosis register
Authors
Maria Trojano
Roberto Bergamaschi
Maria Pia Amato
Giancarlo Comi
Angelo Ghezzi
Vito Lepore
Maria Giovanna Marrosu
Paola Mosconi
Francesco Patti
Michela Ponzio
Paola Zaratin
Mario Alberto Battaglia
on behalf of the Italian Multiple Sclerosis Register Centers Group
Publication date
01-01-2019
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 1/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3610-0

Other articles of this Issue 1/2019

Neurological Sciences 1/2019 Go to the issue